Related by context. All words. (Click for frequent words.) 57 commercialize 57 obtaining regulatory approvals 56 NeoLipid drug 56 Zemiva TM 55 Azedra TM Onalta TM 55 targeting Inflammatory Bowel 54 vii Cubist ability 54 include PLX IBD 54 plastic photochromic lens 54 molecular chaperone regulation 54 successfully commercialized 54 ability tosuccessfully 53 Zemiva ™ 53 concerning CombinatoRx 53 Onalta ™ 52 novel L DOS# 52 Mago ® 52 manufacture PolyHeme 52 offerings visit www.balqon.com 52 DOS# 52 immunotherapies 2A/Furin 52 Cintredekin Besudotox 52 Prelude SkinPrep Systems 52 Zemiva TM Trofex TM 52 Generx TM 52 partner lorcaserin APD# 52 TP# CETi 1 52 SARMs 52 successfully commercialize Iluvien 52 using VIAdel TM 51 Nektar proprietary 51 PolyHeme successfully 51 SANCTURA R 51 OLIGON technology 51 Prednisporin TM 51 Allovectin 7 r 51 VeraTag assays 51 Exelixis compounds 51 Shire Attention Deficit 51 Trofex ™ 51 ADVENTRX 51 OSI Pharmaceuticals filings 51 dimesylate Attention Deficit 51 Azedra ™ 51 XL# XL# XL# XL# 51 prostone 51 Rexahn 51 Fodosine TM BCX 51 Intermezzo ® zolpidem tartrate 51 FalconStor OEM 51 ourability 50 XL# anticancer compounds 50 incur unanticipated 50 Solazed ™ 50 successfully integrate 50 Solazed TM 50 Neo Urinary Conduit 50 HepDirect 50 Ibis T# TM 50 Locked Nucleic Acid 50 Symphony tCGM 50 TOCOSOL Camptothecin 50 incorporating FalconStor 50 EPIX Pharmaceuticals 50 Neo Kidney Augment 50 Aerosurf 50 RXi Pharmaceutical Corporation 50 Dyax phage display 50 CholeraGarde R Peru 50 molecular imaging radiopharmaceutical 50 AzaSite Plus 50 PS# Pharmacopeia ability 50 EGRIFTA TM 49 TriPath Oncology 49 UltiMAb ® 49 AN# novel 49 vii 49 Plasma Converter TM 49 proprietary LNA 49 HepeX B 49 HydroFix ™ 49 oncolytic virus therapies 49 TOCOSOL Paclitaxel 49 Kosan dependence 49 c SIGA 49 Solexa ® 49 Rotarix ® 49 RenaZorb 49 UltiMAb 49 Enhance Biotech 49 ZymoGenetics intends 49 outlicense 49 developing ostarine selective 49 EpiCept NP 1 49 reformulates existing FDA 49 Bioral 49 EMPOWER pivotal trial 49 risks anduncertainties 49 scalable PLX PLacental 49 Shire plc Attention Deficit 48 TOCOSOL 48 successfully commercialize REOLYSIN 48 tivozanib AV 48 PD2i ® algorithm 48 successfully commercialize Silenor 48 repopulate CNS 48 faropenem 48 eTag assays 48 anti CD3 monoclonal 48 LPM TM 48 generic Copaxone 48 advanced polymer conjugate 48 Iluvien ® 48 Ceragenin ™ technology 48 without limitation Terremark 48 proprietary capillary aerosolization 48 TRANSDUR Sufentanil 48 Innovative Biosensors 48 ProteinChip 48 develop electroporation 48 rheumatoid arthritis thrombocytopenia 48 BeadArray TM VeraCode 48 Hyperactivity Disorder ADHD 48 CORLUX CORT # 48 MethyPatch 48 KL4 Surfactant 48 unique PER.C6 ® 48 proprietary intranasal insulin 48 candidate MyVax 48 chemosaturation system 48 TRIOLEX HE# APOPTONE HE# 48 develop PS# 48 Linjeta TM 48 biomimetics non 48 limitedto 48 Eligard R 48 proprietary MSCRAMM ® 48 RetroMetabolic Drug Design 48 Immtech scientists 48 proprietary DuraSite ® 48 tiapamil 48 Etubics 48 novel proprietary KL4 48 inflammatory autoimmune diseases 48 MGCD# MGCD# [001] 48 synthetic retinoid 48 vernakalant oral 48 intranasal insulin product 48 commercialize NicVAX 48 incorporate proprietary Microvolt 48 #CL# 48 unique PER.C6 48 MGCD# MGCD# [002] 48 requisite regulatory approvals 48 targeted radiotherapeutic 48 AzaSite Xtra 48 Chimigen TM 48 ELEVESS 48 biosurgical 48 HuCNS SC 48 Puricase PEG uricase 47 deploy MDCE services 47 BeadArray ™ VeraCode ® 47 v Nastech 47 candidate AQ4N 47 encapsulates siRNAs 47 THR beta agonist 47 sumatriptan DosePro 47 patented Bioral 47 VYVANSE TM lisdexamfetamine 47 immuno inflammatory disease 47 Captisol enabled 47 KRYSTEXXA TM pegloticase 47 DSL.net s 47 biotherapeutic drugs 47 forward lookingstatements 47 miRNA therapeutics 47 Cobalamin 47 topical anti infective 47 Topical Interferon Alpha 2b 47 commercialize becocalcidiol patented 47 manufacture RISPERDAL CONSTA 47 proprietary PEGylation 47 Bioaccelerate compounds under 47 acne impetigo 47 i Immtech 47 HepDirect R 47 infringed misappropriated invalid 47 therapy Atrigel R 47 sirtuin modulators 47 BioGold Fuels 47 Dyax logo 47 commercialize lorcaserin 47 ALTROPANE R 47 proprietary Capillary Aerosolization Technology 47 forodesine HCl 47 DosePro TM 47 Bioral Amphotericin B. 47 novel anti infective 47 products visit www.sucampo.com 47 Sangamo ZFP technology 47 silico predictive discovery 47 involving hydrophilic liquid 47 proprietary transdermal 47 cancer immunotherapies 47 alemtuzumab MS 47 systemic immunosuppressive drugs 47 anti infective treatments 47 Intellon ICs 47 Thalomid R 47 HuCNS SC ® 47 avian transgenic 47 patented Bioral R nanocochleate 47 regarding Heska 47 KIF6 Genotyping Assay 47 Novasome R 47 develop viable ZENNergy 47 Sular formulation 47 Targeted Chemotherapy 47 ELADUR 47 taste modulators 47 RECOTHROM R 47 sublicense agreements 47 novel RNAi therapeutics 46 selective androgen receptor modulators 46 without limitation Newlook 46 Poly ICR 46 commercialize microRNA 46 modified glutathione analog 46 Exelbine 46 CINTREDEKIN BESUDOTOX 46 PrevOnco 46 dihydrochloride Phase 3 46 commercialization 46 vernakalant iv 46 OTCBB CHKT biotechnology 46 Personalized Immunotherapy 46 Perflubutane Polymer Microspheres 46 Surfaxin LS 46 clinical trials 46 antisense drugs 46 ZFP Therapeutics 46 Bacterin develops manufactures 46 Soliris eculizumab 46 stimulate insulin secretion 46 M Enoxaparin 46 XP# XP# 46 OvaRex R 46 oxandrolone USP 46 polymer platinate 46 Cardium Therapeutics TM 46 Fampridine SR Acorda Therapeutics 46 Allovectin 7 R 46 gastrointestinal GVHD include 46 testosterone buccal system 46 forodesine hydrochloride BCX 46 hyperimmune products 46 lender consents 46 Asentar TM 46 GlycoPEGylation TM technologies 46 bulk amorphous alloys 46 commercially recoverable due 46 commercialize ZYFLO CR 46 GVAX Immunotherapies 46 sNDAs 46 leading lipid nanoparticle 46 opinions visit blog.radvision.com 46 Azixa ™ 46 LentiVector 46 bioadhesive drug 46 MassARRAY platform 46 DPX Survivac 46 adversely affecting Cubist 46 Synvista Therapeutics filings 46 Entereg R 46 PEGylation technology 46 Metallophile ™ Technology 46 proprietary Vitoss TM 46 FavId 46 NurOwn 46 GPR# agonist 46 TIMERx 46 commercialize BiDil 46 otherfactors 46 liposomal delivery 46 include Altastaph TM 46 notlimited 46 INNOVIVE 46 Hybridon 46 especially Copaxone ® 46 Chimigen 46 causeactual results 46 Transdel TM 46 SYCREST 46 differmaterially 46 Captisol ® 46 crinobulin 46 oral taxane 46 Pentad TM 46 SEBIVO 46 STRIANT ® 46 molecular chaperone 45 SMaRT ™ 45 Celacade TM System 45 SynthRx 45 iii Cubist 45 novel antiviral therapeutics 45 Thrombin topical Recombinant 45 preclinical 45 TKM ApoB 45 Prednisporin 45 incorporate CXA 45 PERCIVIA 45 cadence regulatory approvals 45 candidate Zemiva TM 45 Nasdaq ITLN 45 Hextend R 45 uncertainties 45 clinically differentiated 45 BioSante licensees 45 rxRNA 45 Bioenvision compounds under 45 IMPACS R 45 capture exosomes 45 BEMA Granisetron 45 rusalatide acetate 45 Rescula 45 patented NanoStat ™ 45 Innovative Biosensors Inc. 45 render PolyHeme obsolete 45 VeraTag technology 45 Prism Pharmaceuticals 45 GVAX cancer 45 oral transdermal 45 candidate Ramoplanin 45 carbonate Direct FuelCell 45 transfection reagents 45 TASE EVGN.TA 45 novel therapeutic modality 45 Insegia 45 intravenous AAT 45 vii IBC 45 risks uncertainties 45 LNP formulations 45 Onalta 45 severe hypercholesterolemia 45 Glycosan 45 Rosetta Inpharmatics technologies 45 PharMerica LTC Transaction 45 VeraTag 45 anticancer compounds 45 LEP ETU 45 photodynamic therapy dermatology 45 STRIANT R 45 pharmacogenomic tests 45 commercialize axon regeneration 45 ELADUR TM 45 intranasal vaccines derived 45 ParAllele 45 Local.com domain 45 Yima project 45 TRISENOX R 45 Adnectin 45 PDL# 45 newproducts 45 serious systemic Staphylococcal 45 candidates Azedra TM 45 treat refractory angina 45 www.vivakor.com 45 NovaDel oral spray 45 CollaFix ™ 45 defensin mimetic antibiotic 45 treat GI GVHD 45 Rexahn licensees 45 proprietary Isolagen Process 45 Calixa 45 valtorcitabine 45 Convivia TM 45 GPR# agonists 45 substantial indebtedness 45 FACTIVE R gemifloxacin 45 proprietary BiTE ® 45 AdVac R 45 Alfacell proprietary ribonuclease 45 Maxy G# 45 InterfeRx TM 45 theranostic 45 CytoCore Solutions System 45 Cutanea 45 HERmark assay 45 eligen R technology 45 CCR5 inhibitors entry 45 peramivir BCX 45 please visit www.middlebrookpharma.com 45 Alnylam RNAi 45 viii 45 MDx tests 45 PentaLyte R 45 novel peptides 45 TRANSDUR ™ 45 Syntroleum Process 45 OMNARIS HFA 45 visit www.targanta.com 45 Immtech clinical trials 45 mGluR4 mGluR2 45 VaxImmune 45 risksassociated 45 PROfusion 45 therapeutic Nanobodies 45 Entereg TM 45 molecular diagnostic reagents 45 bardoxolone 45 commercialize dutogliptin 45 TRISENOX ® 45 Perihelion Global focuses 45 TM Aganocide 45 staphylococcal vaccines 45 Oracea TM 45 avian influenza viral infections 45 candidate XP# 45 NovaBay Aganocide compounds 45 CdTe Si 44 cicletanine 44 Hiru Corporation estimate 44 Scivanta 44 BC SeraPro ™ 44 crolibulin TM 44 xix 44 market PolyHeme commercially 44 FOX MTX 44 APTIMA HPV assay 44 AcryMed technologies 44 HandHeld Entertainment filings 44 Dynepo 44 DIFICID ™ 44 systemic RNAi 44 signal averaging electrocardiography 44 novel immunomodulatory 44 IAP inhibitors 44 noninvasive prenatal tests 44 LE SN# 44 IV APAP 44 hoFH 44 Urokinase 44 markets HP Acthar 44 RECEPTORS LLC 44 androgen receptor modulator 44 platforms GVAX 44 Orbix R 44 Nabi HB R 44 RECEPTORS 44 3G WCDMA HSDPA 44 #.#G HSDPA communication 44 Genaera 44 JOULFERON 44 phage display technology 44 KAI Pharmaceuticals 44 advance Debio 44 InPath TM System 44 MAb therapy 44 bafetinib 44 CoTherix logo 44 Heska reliance 44 technology cHTS 44 IMiDs 44 factor VIIa 44 Risks uncertainties 44 Cerashield ™ 44 Canvaxin TM 44 DURECT proprietary 44 stem cell therapeutics 44 commercialize Aganocides 44 OTCBB JMAR 44 Tekmira lipid nanoparticle 44 Sulonex TM 44 Zanaflex Capsules 44 ATryn ® 44 AcryMed Incorporated 44 BACcel 44 Dyloject TM 44 nausea vomiting BEMA Granisetron 44 regulatory authorizations 44 Nektar pulmonary 44 molecular therapeutics immunotherapies 44 OrCrude TM process 44 Ondansetron Injection 44 CoStar stent 44 LandStar Inc. s 44 Potelligent 44 orBec R 44 Protonix ® 44 research anddevelopment 44 ProBiora3 ® 44 Taiho Pharmaceutical 44 PharmFilm ® 44 extract coalbed methane 44 treat male hypogonadism 44 therapeutic monoclonal antibody 44 ZENNergy TM drivetrain 44 Prelude SkinPrep System 44 Ibis T# 44 Embryome Sciences 44 PerClot 44 ADVEXIN clinical 44 immunotherapeutic approaches 44 Somaxon ability 44 fluorinated carbohydrate mimics 44 risksand uncertainties 44 statements arebased 44 buccal delivery 44 affecting ChinaNet 44 adrenergic regulation 44 Isis Alnylam 44 CarePoint suite 44 personalized dendritic 44 intravenous formulations 44 Acorda Therapeutics intellectual property 44 ULTRIO 44 Pancreate 44 ThermaVolt 44 CalciTech products 44 identify protein biomarkers 44 orBec ® oral beclomethasone 44 Biologics License Application 44 menstrual stem cell 44 MassARRAY ® 44 developing ACAPODENE 44 sequencing gene expression 44 TFChem licenses 44 SILENOR 44 StaphVAX 44 Tekturna Rasilez 44 Enhanze 44 epothilone 44 Restoraderm 44 Immunicon dependence 44 Aganocide 44 governmental approvals 44 BOPET film 44 integrative pharmacology 44 sodium glucose transporter 44 IVAX Diagnostics 44 Nycomed GmbH 44 ACAPODENE R 44 zolpidem tartrate sublingual tablet 44 diagnostic assays 44 Nasdaq RXII 44 Inc. NASDAQ ZLCS 44 Vitamin D analogue 44 Levoleucovorin 43 Solzira TM 43 Thelin tm 43 intercompany arrangements 43 Isis antisense 43 Vivotif 43 adapt AVANT vectoring 43 Rami Efrati CEO 43 Selective Electrochemical Tumor Ablation 43 PDTI 43 Ambrx 43 Lovaza TM 43 biobased succinic acid 43 NuMimetic TM 43 SANCTURA SANCTURA XR NEBIDO 43 differ materially fromthose 43 vaginal lidocaine 43 platinum chemotherapeutic 43 HealthGate ability 43 Affilin ® 43 Genaissance 43 using ImmunoGen TAP 43 ii GTx may 43 PER.C6 r 43 DelSite Biotechnologies subsidiary 43 rolapitant 43 BioSilicon TM 43 oral ferric iron 43 Aversion r Technology 43 retain drilling rigs 43 Micromet proprietary BiTE 43 PER.C6 43 synthetic nucleic acid 43 PEG PAL 43 Sepracor patents 43 AGTC 43 Preotact R 43 proprietary phage display 43 pharmacological chaperone 43 diagnostic radiopharmaceutical 43 HYVISC R 43 OFIRMEV 43 xxii 43 gastrointestinal disorders ATI 43 NeutroPhase TM 43 Targeted Immunotherapy 43 affecting Amarin 43 Salmedix 43 visit www.genmab.com 43 novel antibody therapeutics 43 opioid tolerance 43 BENLYSTA ® 43 Asentar ™ 43 Local.com domain incorporate 43 enforce MOSAID 43 PD2i Analyzer 43 vivo fluorescence imaging 43 NanoCrystal technology 43 SEQureDx TM 43 cause actual 43 SensiGen 43 Naglazyme R 43 CoVal TM fusion 43 Linjeta ™ 43 Hemopurifier ® 43 RECOTHROM ® 43 Alfa Wassermann 43 topical dermatology 43 Staccato nicotine technology 43 including Random Activation 43 PentaStaph 43 intellectual property rights 43 Transfection Reagent 43 IMPDH inhibitor 43 Visudyne R 43 orthobiologic 43 small molecule PEGylation 43 eligen 43 Allovectin 7 43 Cephalon GlaxoSmithKline Organon 43 currentexpectations 43 proprietary punctal plug 43 BeadArray technologies 43 Manufacturer OEM 43 rhPDGF BB platform 43 RenaZorb TM 43 interventional vascular technology 43 nasal bepotastine 43 Accelerated Intelligent 43 Therapeutic Diagnostics 43 ourproducts 43 looking statementsare 43 molecular diagnostic kits 43 VioQuest 43 Interpharm 43 RainStorm 43 O# Essential Oil 43 rapid technological 43 commercialization milestones 43 surgical cryoablation 43 Veronate R 43 HuCAL GOLD ® 43 proprietary albumin fusion 43 websites www.industrial nanotech.com 43 product platforms AZX# 43 Oxygent 43 Symphony tCGM System 43 Chaim Lebovits President 43 commercialize technological innovations 43 refractory chronic lymphocytic 43 novel MetAP 2 43 Zanaflex Capsules competition 43 LibraGen 43 LPM ™ 43 HuCAL GOLD R 43 CysDisplay 43 isoform selective 43 differ materiallyfrom 43 HyProStar Hydrogen Generator 43 commercialize deforolimus 43 Rexahn actual 43 ReCyte 43 superior biotherapeutics 43 autoimmune indications 43 Locked Nucleic Acid LNA 43 NYSE Amex PBTH 43 Syrrx 43 Telik logo TELINTRA 43 productdevelopment 43 boron chemistry 43 proprietary encapsulation 43 salmon calcitonin heparin 43 BioGlue ® 43 InterfeRx 43 Surface Plasmon Resonance SPR 43 commercialize CorMedix drug 43 Avivo Corporation 43 Inovio Annual Report 43 Unit Dose Budesonide 43 Rhucin ® recombinant 43 PREOS R 43 IZOD ARROW Bass 43 Prodarsan R 43 Hycor 43 celgosivir 43 AFFITOME R 43 molecular imaging radiopharmaceuticals 43 HuMax TAC 43 candidate deforolimus 43 AdVac 43 NeutroTest 43 DCVax R Prostate 43 Phage Pharmaceuticals 43 ZFNs clinical trials 43 Syntonix 43 EP #R 43 novel ZFP TFs 43 Tostrex 43 www.miraculins.com 43 ZaBeCor 43 MTI MTI Micro 43 Femprox ® 43 Sepracor anticipates 43 Sopherion 43 pharmacokinetic feasibility 43 corticotropin injection 43 Cellegesic 43 JAK2 inhibitor 43 STEDESA 43 OREXIGEN 43 Avian Transgenic Technology 43 mGluR2 mGluR4 mGluR5 mGluR7 43 uncertainties materializes FICO 43 Pharmacopeia Phase 43 include ClindaReach TM 42 PolyMedix compounds 42 factor factor VIIa 42 cintredekin besudotox 42 NovaScreen 42 d SIGA 42 Stimuvax R 42 Nicotine Conjugate Vaccine 42 refinance indebtedness 42 NeutroSpec TM 42 OPAXIO pixantrone 42 sterile lidocaine patch 42 HuCAL PLATINUM R 42 HepatAssist TM 42 See http:/www.chdtcorp.com 42 Zensana 42 therapeutics diagnostics 42 OGeS 42 LiverPool 42 please visit http:/www.Motorola.com 42 TrueKnowledge Platform TM 42 Pure Biofuels ability 42 collect reinsurance recoverables 42 manufacturing interventional vascular 42 recombinant biopharmaceutical 42 KRYSTEXXA 42 PER.C6 ® production 42 Sunesis clinical trials 42 vii Dynamic 42 R DYNACIN R 42 Duromist ™ 42 Purifine ® PLC 42 Oligator R oligonucleotides iv 42 Corixa Corporation 42 CCR9 antagonist 42 PROCHIEVE ® 42 Tekmira intellectual property 42 EV# vaccine 42 SOLODYN R 42 http:/www.thqwireless.com 42 rThrombin 42 Atrisorb D R 42 prescription brands RESTYLANE 42 AVEO integrates proprietary 42 injectable depot 42 therapeutic monoclonal antibodies 42 EcaFlo R 42 Soliris TM eculizumab 42 Kiadis 42 MOZOBIL 42 Vicor anticipates 42 OTCBB HXBM developer 42 Evader Inc. 42 Rotarix R 42 gastrointestinal mucositis 42 Neo Kidney Augment ™ 42 Copegus R 42 TSX VENTURE GAP 42 RAPIDGate Program contains 42 hypoxia activated prodrug 42 ADSI reliance 42 technology platforms photodynamic 42 Staphylococcus aureus Immune Globulin 42 PROMACTA ® 42 #L Sterilizer 42 suchstatements 42 regulatory approvals 42 Cellerant 42 DNA methylation biomarkers 42 SUMAVEL 42 Phase IIa clinical trials 42 xiii 42 HCV protease inhibitors 42 Eckard Weber 42 looking statements 42 dipeptidyl peptidase IV 42 BioFocus DPI Galapagos 42 Organ Regeneration Platform 42 Obtains Exclusive License 42 SUPPRELIN LA DELATESTRYL 42 ENABLE Phase 2 42 acquisitions mergers dispositions 42 GRAS determination 42 Alseres Cethrin 42 PyraDerm TM 42 topical dermatological products 42 suchforward looking 42 Xcyte Therapies 42 LFRP 42 Viamet 42 molecular imaging pharmaceuticals 42 SonoPrep device 42 Nasdaq MRNA 42 TFChem 42 VIOXX Lawsuits 42 anti emetic therapy 42 BioGlue R 42 NeoVisc R 42 transport cystine 42 AttoSense 42 OraDisc TM 42 Discovery Labs 42 adrenal steroid hormones 42 Nasdaq RXII recognized 42 Amlodipine Besylate 42 Metabasis stockholders 42 Vitaros 42 These statementsare 42 Omigard 42 Filtran Microcircuits Inc. 42 cinacalcet HCl 42 Apthera 42 Civacir 42 Lumacan 42 AMITIZA lubiprostone 42 Charlesson 42 novel immunotherapies 42 Biologic License Application BLA 42 Commercialize 42 SIMPLE Antibody TM 42 XML UDDI Universal 42 Orapred ODT 42 Vaccinex 42 collaborations Pharmacopeia 42 Tyzeka Sebivo 42 itsproducts 42 www.biospecifics.com 42 Novasome R adjuvant 42 iPSC technology 42 Captisol 42 recombinant vaccines 42 R bivalirudin 42 IND enabling 42 Caliper Driven 42 Cerashield 42 Colaris Colaris AP 42 Surfactant Replacement Therapies 42 tosuccessfully 42 ViroChem 42 biologic therapeutics 42 OptiCon R4 42 NeuroHealing 42 treats acute lymphoblastic 42 without limitation 42 bioREV 42 commercialize Aganocide compounds 42 Shin Poong 42 VANTAS 42 SIX RO ROG 42 multiplex immunoassay 42 histone deacetylase HDAC inhibitors 42 www.stptools.com 42 aptamer therapeutics 42 Dicer Substrate Technology 42 rapamycin derivatives 42 MetaDrug TM 42 PrevOnco ™ 42 RPTN common 42 MASCT System 42 therapeutics 42 commercially feasible 42 vinorelbine emulsion 42 MolecularBreeding 42 Pixelplus cautions readers 42 HemoTech TM 42 GLP toxicology studies 42 looking statements.Such 42 Inc. OTCBB ICPR.OB 42 Clean Diesel patented 42 Quark Biotech 42 PDE4 inhibitor 42 Hiru Corporation 42 MONOVISC 42 Bellicum 42 Safe Harbors created 42 EHT AGN 42 immunotherapeutics 42 initiated Phase 1b 42 Ibis T# biosensor 42 RNA antagonists 42 Pain Neutralizer holds 42 concerning Alexza 42 non personalized allogeneic 42 Cyclosert TM 42 transcatheter valve technologies 42 AMEX OTD 42 nonclinical studies 42 Synerx Pharma 42 andmarket 42 eTelcharge.com Inc. 42 methemoglobin SpMet 42 punctal plug drug 42 orBec ® 42 novel emulsion formulation 42 www.thermoenergy.com 42 visit www.adm.com 42 www.sensio.tv 42 Ascend Therapeutics 42 http:/www.nansulate.com 42 Loramyc TM 42 TransVax tm 42 AeroLEF R 42 please visit www.medicinova.com 42 punctal plug 41 Circ Pharma 41 NASDAQ ONTY 41 Glassia 41 regenerative therapeutics 41 Tß4 41 intravenous acetaminophen 41 recombinant antibodies 41 ANDA submission 41 Ceragenin 41 Nereus Pharmaceuticals 41 EpiCeptTM NP 1 41 Cobalamin TM mediated 41 Meritage Pharma 41 LOPROX R 41 CCG TH# 41 ebXML Electronic Business 41 commercially recoverable 41 EcaFlo TM 41 Acetavance TM 41 commercialize conjugates consisting 41 torsemide ER 41 therapeutically beneficial 41 differ materially 41 CysDisplay R 41 ruxolitinib 41 Illumigen Biosciences Inc. 41 EHSK 41 ZALBIN 41 HP Acthar R 41 CEFF financings subject 41 AKIP ™ 41 deploy GigaBeam 41 TaiGen 41 referenced investigational 41 Estrasorb 41 Sebivo 41 Cholestech Corporation 41 x Immtech 41 OraTest R 41 polymeric formulations 41 INTEGRILIN ® 41 AQUA ® 41 Sionex 41 affect Pennichuck Corporation 41 lixivaptan 41 OrthoCyte 41 Aradigm Logo 41 sublicensees 41 CeNeRx BioPharma 41 substantiate CytoCore expectations 41 NEBIDO R 41 Taligen Therapeutics 41 blood clot dissolver 41 GlycoPEGylated hemostasis compounds 41 VitiGam 41 Pruvel ™ prulifloxacin 41 Pics section 41 Xclair R 41 custom oligonucleotides 41 bioinnovation 41 Catalyst Biosciences 41 evaluating bafetinib 41 segments SAFC Pharma 41 adverse determinations 41 Novartis Wyeth 41 Firazyr ® 41 Phase III clinical trials 41 subsidiaries visit http:/www.apricusbio.com 41 anduncertainties 41 lorcaserin NDA 41 aresubject 41 Novartis NVS Snapshot Report